通过纵向数据驱动集群预测新诊断的帕金森病的认知和情感变化
Benjamin Ellul1, Angus McNamara1, Stephan Laurenz2,3
1School of Biomedicine, The University of Adelaide, Adelaide, SA, Australia.
Journal of geriatric psychiatry and neurology
|August 12, 2025
概括
预测帕金森病的认知和情感衰退涉及基线认知和情感状态,加上大脑脊髓液中粉样β和酸化的水平. 这些生物标志物有助于预测非运动症状的进展.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物标志物研究 生物标志物研究
背景情况:
- 帕金森病 (PD) 主要是一种运动障碍,但诸如认知衰退和情感功能障碍等非运动症状显著影响生活质量.
- 在PD中影响这些非运动症状轨迹的因素尚未完全理解.
- 准确预测非运动性症状进展对于患者管理和治疗发展至关重要.
研究的目的:
- 在患有帕金森病的个体中,在5年内确定认知和情感功能的预测因子.
- 利用进步帕金森标志物倡议的数据来分析长期症状轨迹.
- 探索已确定的神经认知生物标志物在预测PD非运动结果中的实用性.
主要方法:
- 模糊的C-means集群被用于根据5年认知和情感功能对患者进行分组.
- 用基线数据分析了集群成员资格的预测因素,包括认知,情感和运动分数.
- 脑脊液 (CSF) 中的粉样β和酸化的水平被评估为潜在的生物标志物.
- 使用支向量回归模型来评估分类准确性.
主要成果:
- 两个不同的集群出现了,其中一个组 (n=96) 在5年的随访中表现出更老的年龄和更差的认知,情感和运动功能.
- 基线认知和情感功能,中枢神经液粉样β下降和中枢神经液酸化的增加显著预测了5年后的集群成员资格.
- 结合这些预测因素的机器学习模型,与单独的基线评估相比,将分类准确度提高了5%.
结论:
- 其他神经认知障碍的已知生物标志物,特别是粉样β和酸化,对于预测帕金森病的认知和情感轨迹非常有价值.
- 除了临床症状之外,预后标记的多模式面板可以告知PD认知和情感结果的预后.
- 这种方法可能有助于更早地为患有PD非运动障碍高风险的个体开发个性化干预措施.
关键词:
这就是为什么MRI是MRI.警方 警方 警方 警方这就是为什么PPMI是PPMI.集群集成是指集群集成.这是神经精神病学治疗.黑色物质 (substance nigra) 是一个黑色物质.分类子类型 分类子类型更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.0K
14:27Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.8K
相关概念视频
Parkinson's Disease: Overview
704
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
704
Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
